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The bone marrow microenvironment represents a “metastatic niche” in which prostate cancer cells may
persist and evade cytotoxic therapy. In order to study the biology of prostate cancer dissemination, we
have established a safe and efﬁcient method for performing pubic bone marrow aspiration at the time of
radical prostatectomy. We herein describe our experience with this technique.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
There is increasing evidence that metastatic cancer cells utilize
the microenvironment of the bone marrow (BM) as a “metastatic
niche” in which they can persist and grow.1,2 The clinical signiﬁ-
cance of a limited population of cancer cells reaching the marrow,
however, is unclear. To facilitate investigation of this phenomenon,
we sought to establish efﬁcient methodology for assessment of the
BM milieu in menwith prostate cancer. Herein we present the case
of one such participant and describe our novel approach.Case presentation
A 65 year-old Caucasian male presented with serum PSA of
9.35 ng/mL and a small left-sided nodule on digital rectal exami-
nation (clinical stage T2a). Transrectal ultrasound-guided 12-core
biopsy revealed Gleason score 4 þ 5¼9 adenocarcinoma in two of
two cores from the left apex, as well as Gleason score 4 þ 3¼7 and
4 þ 4¼8 in the left mid-gland and base, respectively. 99mTc-meth-
ylene diphosphonate whole body bone scan was negative. As such,
the patient was diagnosed with clinically localized high-risk
localized prostate cancer.rg 134, Baltimore, MD 21287,
Inc. This is an open access article uAfter appropriate counseling, the patient elected to undergo
robot-assisted radical prostatectomy (RARP). The patient was
informed of our bone marrow aspiration (BMA) protocol and the
risks and beneﬁts of participation. He ultimately elected to partic-
ipate and provided written informed consent. The study protocol
was approved by the institutional review board at the Johns Hop-
kins Medical Institutions.
Our study protocol was developed for intra-operative obtain-
ment of BMA at the time of radical prostatectomy. The patient was
treated with general anesthesia per routine. Aspiration was ob-
tained from the pubic bone using a standard manual device
(11G x 100 mm Hospital Trapsystem e HS Hospital Service S.p.A.,
Aprilia, Italy) as demonstrated in Video 1.
Ten cubic centimeters of aspirate was obtained; total procedure
time was approximately 1 min. RARP was performed without
complication. The patient recovered from surgery without
complication and reported no pain at the site of BMA. He was dis-
charged on postoperative day one. His ﬁnal pathology revealed
organ-conﬁned Gleason score 4 þ 5¼9 prostate adenocarcinoma;
surgical margins and 21 obtained lymph nodes were negative for
tumor.Discussion
There is great interest in better understanding tumor dissemi-
nation and persistence in non-native environments. Bone marrow
represents a common site of metastasis in men with advancednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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microenvironment remains limited. Despite playing a central role
in the evaluation of hematologic disorders, bone marrow aspiration
has traditionally represented a clinically burdensome procedure
associated with signiﬁcant discomfort. BMA has most frequently
been described from the posterior superior iliac crest,4,5 with
adequate samples obtained in less than 50% of cases in some series.
The inefﬁciency of these methods presents a signiﬁcant limitation
to our understanding of the metastatic process.
In this report, we have demonstrated a percutaneous approach
to BMA, which we have routinely used prior to RARP for men in the
lithotomy position. We have similarly derived an open approach for
use prior to traditional retropubic radical prostatectomy (Video 2).
In some cases, aspiration was performed percutaneously during
open procedures due to physician preference. To this point, these
methods have demonstrated great success; at the time of analysis,
aspirate was successfully obtained in 173 of 180 attempts (96.1%; 99
of 101 open, 74 of 79 percutaneous). All samples analyzed to date
have been adequate for bone marrow analysis. These ﬁndings
suggest the pubic bone is an acceptable site to obtain BMA and may
be comparable to the more commonly described iliac crest. We
believe these methods provide an efﬁcient means by which the
surgeon can routinely obtain bone marrow aspirate.
Conclusion
This report details our initial experience performing bone
marrow aspiration at the time of radical prostatectomy. Thesemethods have proven to be effective and are associated with min-
imal patient discomfort, thus, we believe this approach may prove
useful to others in the appropriate setting.Conﬂict of interest
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